Autoinjectors market is anticipated to grow at a CAGR of 19.0% from 2019 to 2030.
The global autoinjectors market is driven by growing popularity of targeted therapies and increasing number of regulatory approvals. Moreover increasing incidences of anaphylaxis, availability of generic versions of autoinjectors and growing geriatric population is anticipated to further contribute to the growing demand of the global autoinjectors market during the forecast period. However, availability of conventional drug delivery systems like syringes s likely to restrain the market to a certain extent.
Major Key Players of the Autoinjectors Market are:
Abbvie, Mylan, ELI Lilly, Ypsomed, Amgen, Becton Dickinson and Company, Owen Mumford, Consort Medical, Haselmeier and Shl Group among others.
No comments:
Post a Comment